@misc{indiciae120fe43a8ac0,
  title = {Virus-like particle (VLP)-based vaccine targeting tau phosphorylated at Ser396/Ser404 (PHF1) site outperforms phosphorylated S199/S202 (AT8) site in reducing tau pathology and restoring cognitive deficits in the rTg4510 mouse model of tauopathy.},
  author = {Hulse, J. P. and Maphis, N. M. and Peabody, J. and Chackerian, B. and Bhaskar, K.},
  year = {2024},
  doi = {10.1101/2024.04.05.588338},
  url = {https://www.biorxiv.org/content/10.1101/2024.04.05.588338v1},
  note = {Source identifier: 10.1101/2024.04.05.588338}
}